Ligand-induced receptor dimerization is an early functional step in receptor activation, representing the most proximal, functional readout for Interleukin receptors.…
Read MoreSearch results: “TIP”
Showing 25–34 of 34 results
Regulatory authorities define biosimilars as drugs that are “highly similar” to or “interchangeable” with an approved biologic. The lack of…
Read MoreAntibody-dependent cell-mediated cytotoxicity (ADCC) is the mechanism by which many Class I therapeutic antibodies, including rituximab and trastuzumab, achieve clinical…
Read MoreThe screening and functional characterization of novel ligands for G-protein-coupled receptors (GPCRs) remains a key activity in drug discovery process.…
Read MoreAs more is learned about the intricacies of GPCR signaling, the harder it becomes to accurately describe ligand activity using…
Read MoreWith the increasing industry focus on antibody drugs, there is an ever-greater need for functional bioassays that interrogate the therapeutic…
Read MoreView validation data for diverse kinases. Cellular target engagement potency data for multiple kinase inhibitors Dose response curves for under-studied…
Read MoreAs more is learned about the intricacies of GPCR signaling, the harder it becomes to accurately describe ligand activity using…
Read MoreRobust, Ready-to-Use ADCC & ADCP Bioassays to Accelerate Your Drug Development Program The KILR® cytotoxicity assay platform developed by Eurofins…
Read MoreAuthors: Kramer J, Himmel HM, Lindqvist A, Stoelzle-Feix S, Chaudhary KW, Li D, Bohme GA, Bridgland-Taylor M, Hebeisen S, Fan…
Read More